Articles sur Vaccines

Affichage de 1 à 20 de 267 articles

On Aug. 11, Russian President Vladimir Putin announced that a coronavirus vaccine developed in the country has been registered for use. Russian Health Ministry/Handout/Anadolu Agency via Getty Images

A COVID-19 vaccine needs the public’s trust – and it’s risky to cut corners on clinical trials, as Russia is

As Russia fast tracks a coronavirus vaccine, scientists worry about skipped safety checks – and the potential fallout for trust in vaccines if something ends up going wrong.
A scientist holding a coronavirus vaccine at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Alexander Zemlianichenko Jr/Russian Direct Investment Fund/AP/AAP

Russia’s coronavirus vaccine hasn’t been fully tested. Doling it out risks side effects and false protection

If the vaccine does not protect individuals from infection, those who have been vaccinated could falsely believe they are protected.
Who are in the hoodies? BeeBright/iStock/Getty Images Plus

Russian cyberthreat extends to coronavirus vaccine research

The Russian cyberthreat, now targeting coronavirus vaccine research, goes back over three decades, extends into the country's educational systems and criminal worlds, and shows no signs of letting up.
A new study published in the New England Journal of Medicine, discloses the results from phase 1 of Moderna’s COVID-19 vaccine trials. YurolaitsAlbert / Getty Images

Video: An infectious disease expert explains the results from Moderna’s latest vaccine trials

The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
A researcher wearing a face mask and gloves as a preventive measure inside a laboratory. Chaiwat Subprasom/SOPA Images/LightRocket via Getty Images

Pressure is on to develop a COVID-19 vaccine, but corners can’t be cut

Vaccine development usually spans a number of decades. This is because there's a need to understand the mechanisms of protection against the pathogen, and to minimise adverse reactions.
A volunteer receives an injection from a medical worker during the country’s first human clinical trial for a potential vaccine against COVID-19 in Soweto, South Africa. Felix Dlangamandla/Beeld/Gallo Images via Getty Images

COVID-19 vaccine: the challenges of running a trial in the middle of a pandemic

In a pandemic like this one, the priority is to save lives. But without a vaccine, there's a limit in the tools available to save lives.

Les contributeurs les plus fréquents

Plus